专题:Kruppel-like factors research

This cluster of papers explores the role of Krüppel-like factors and other transcription factors in regulating gene expression, cell growth, and differentiation. It specifically focuses on their involvement in cancer, endothelial activation, proinflammatory signaling, and the maintenance of stem cells. Additionally, it delves into their impact on smooth muscle differentiation and their potential as tumor suppressors.
最新文献
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long-Acting FGF21 Analog Zalfermin: A Multiple Ascending Dose Study in Healthy Participants with Overweight/Obesity

article Full Text OpenAlex

Role of miR34a-KLF4 signaling pathway in podocyte injury in obesity

preprint Full Text OpenAlex

Tectorigenin could alleviate SA-AKI via reducing M1-like polarization of macrophages through KLF4/NF-κB pathway

article Full Text OpenAlex

YY1/INSIG1 enhances atherosclerosis progression by regulating AMPK-mTOR signaling.

article Full Text OpenAlex

ACSS3 protein macromolecule regulates glycolysis in keloid through Wnt/β-catenin signaling pathway: Bioinformatics, machine learning, and experimental validation

article Full Text OpenAlex

Heterogeneous Nuclear Ribonucleoprotein A/B Drives Gastric Cancer and EMT via Akt-GSK3β-Wnt Pathway

article Full Text OpenAlex

Circ_0061825 Acts as a miR-593-3p Sponge to Promote Breast Cancer Progression by Regulating FGFR3 Expression [Retraction]

article Full Text OpenAlex

Correlation between enzymatic antioxidants and FGF21 levels, within the context of pharmacotherapy for non-alcoholic fatty liver disease

article Full Text OpenAlex

Fibroblast Growth Factor 19 Disrupts Cartilage Development Via the FGFR4/β-catenin Axis.

article Full Text OpenAlex

KLF4 overexpression protects against complement-mediated endothelial injury in transplant-associated thrombotic microangiopathy

article Full Text OpenAlex

近5年高被引文献
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial

article Full Text OpenAlex 273 FWCI17.824

Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets

article Full Text OpenAlex 269 FWCI88.94

Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH

article Full Text OpenAlex 268 FWCI41.001

Biology and therapeutic targeting of vascular endothelial growth factor A

review Full Text OpenAlex 239 FWCI12.741

Metabolic Messengers: FGF21

review Full Text OpenAlex 224 FWCI5.358

Life histories of myeloproliferative neoplasms inferred from phylogenies

article Full Text OpenAlex 214 FWCI47.035

β-Catenin signaling in hepatocellular carcinoma

review Full Text OpenAlex 207 FWCI7.13

The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration

review Full Text OpenAlex 201 FWCI3.572

Six Shades of Vascular Smooth Muscle Cells Illuminated by KLF4 (Krüppel-Like Factor 4)

review Full Text OpenAlex 197 FWCI4.919

Primary myelofibrosis: 2023 update on diagnosis, risk‐stratification, and management

review Full Text OpenAlex 191 FWCI16.137